# A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

> **NCT00217152** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 12 (actual)

## Conditions studied

- Kidney Transplantation
- Delayed Graft Function

## Interventions

- **DRUG:** CellCept

## Key facts

- **NCT ID:** NCT00217152
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Roche decided to prematurely terminate study.
- **Last updated:** 2011-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217152, "A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00217152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*